Astrana Health Inc.
ASTH | NASDAQ
$34.25
+$0.70 (+2.09%)
Sep 22, 2026, 1:35 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | 31.58M | 14.44M | 6.56M | 1.08M | 10.22M | 6.22M | -7.78M | 23.7M | 21.87M | 16.86M | -94K | 27.97M | 17.48M | 12.49M | 471K | 23.9M | 11.28M | 11.45M | -19.31M | -5.39M | 59.53M |
Depreciation & Amortization | 31.03M | 15.48M | 16.4M | 15.6M | 6.9M | 6.85M | 8.13M | 7.26M | 7.44M | 5.1M | 4.9M | 4.31M | 4.25M | 4.29M | 4.06M | 4.76M | 4.35M | 4.37M | 4.41M | 4.67M | 4.24M |
Stock-Based Compensation | 21.68M | 9.9M | 11.38M | 7.7M | 11.71M | 7.81M | 15.24M | 6.16M | 7.39M | 5.75M | 8.68M | 5.71M | 4.21M | 3.45M | 5.62M | 3.5M | 3.92M | 3.06M | 2.42M | 1.42M | 1.56M |
Other Working Capital | 18.92M | 26.49M | -39.22M | -15.45M | 58.85M | 5.12M | -29.6M | -14.78M | -2.92M | 6.84M | -39.63M | 9.76M | 9.06M | 6.33M | -6.68M | -14.86M | -3.46M | 50.86M | 6.67M | -15.01M | -4.83M |
Other Non-Cash Items | -5.14M | -149K | 1.36M | 3.99M | 4.82M | 4.11M | -349K | -38.92M | -547K | 8.68M | 2.94M | 2.68M | -3.34M | 4.15M | 2.69M | 6.44M | -1.68M | 7.77M | 26.31M | 58.65M | -63.13M |
Deferred Income Tax | 2.73M | 1.91M | 637K | -2.96M | -1.6M | -358K | 3.35M | -337K | -11K | -7.25M | -8.51M | -190K | -4.03M | 283K | -5.35M | -6.42M | 1.18M | 2.18M | -12.8M | -3.44M | 11.2M |
Change in Working Capital | 18.92M | 26.49M | -39.22M | -15.45M | 58.85M | -8.01M | -29.53M | 36.11M | -12.95M | -23.16M | 11.39M | -25.07M | 7.23M | -16.93M | 77.44M | -68.05M | -10.03M | -4.79M | -13.23M | -4.68M | 7.94M |
Operating Cash Flow | 100.8M | 68.06M | -2.89M | 9.96M | 90.9M | 16.63M | -10.95M | 33.98M | 23.19M | 5.98M | 19.3M | 15.41M | 25.8M | 7.72M | 84.94M | -35.87M | 9.02M | 24.04M | -12.19M | 51.24M | 21.33M |
Capital Expenditures | -7.88M | -4M | -3.06M | -2.55M | -1.42M | -3.07M | -2.53M | -2.3M | -2.84M | -369K | -7.06M | -4.11M | -2.52M | -14.85M | -886K | -3.21M | -1.36M | -17.49M | -2.8M | -9.06M | -7.27M |
Cash Acquisitions | -3.74M | n/a | -51K | -548.55M | 28K | n/a | -34.67M | -1.03M | -73.81M | -50.52M | -1.84M | -5.72M | 350K | -325K | -11.06M | -4.86M | -109K | -2.43M | -1.48M | -7.81M | 1.55M |
Purchase of Investments | n/a | n/a | n/a | n/a | 24K | -24K | 3.88M | -3.93M | -2.53M | -27K | -2.03M | -103K | -3.02M | -1M | -104K | n/a | -1.73M | -21K | -27.23M | 4.11M | -4.79M |
Sales Maturities Of Investments | n/a | n/a | n/a | 15.1M | -100K | n/a | n/a | 124K | n/a | n/a | 491K | n/a | n/a | n/a | 25.23M | -42K | 6.48M | n/a | 66.51M | n/a | n/a |
Other Investing Acitivies | 2.55M | 1.16M | 2.06M | 1.53M | 419K | 700K | n/a | -968K | -750K | -19.99M | -997K | -24.94M | 2K | 2.14M | 16K | 21K | 4.21M | 219K | 2.62M | 10K | 15K |
Investing Cash Flow | -9.07M | -2.84M | -1.06M | -534.47M | -1.05M | -2.39M | -33.32M | -8.11M | -79.93M | -70.91M | -11.43M | -34.88M | -5.19M | -14.04M | 13.2M | -8.09M | 7.5M | -19.73M | 37.61M | -12.74M | -10.49M |
Debt Repayment | -103.93M | -11.97M | -11.97M | 672.58M | -2.98M | -16.38M | -3.89M | -2.37M | 53M | 106.32M | 76.99M | 1.06M | -191K | 1.31M | 1.32M | -2.9M | 225K | 529K | 370K | -73K | -56.53M |
Common Stock Repurchased | -4.36M | -2.91M | -15.43M | -509K | 1.32M | -1.32M | -220K | -717K | -3.58M | n/a | -503K | -150K | n/a | -9.54M | 398K | -168K | -9.25M | -230K | n/a | -2.76M | -2.64M |
Dividend Paid | -199K | -104K | -1.56M | -96K | -778K | -5.46M | -1.92M | -218K | n/a | -95K | -59.81M | -2.27M | -722K | -120K | -1.35M | -120K | -11.38M | -1.18M | n/a | -9.98M | -21.11M |
Other Financial Acitivies | -11.54M | -983K | 2.61M | -23.48M | -5.93M | -21.02M | -9.76M | 112K | -2.16M | 125K | -4.96M | 842K | -50K | 1.25M | 5.51M | -3.06M | 166K | 1.41M | 75K | 1.8M | -17K |
Financial Cash Flow | -120.03M | -15.96M | -26.34M | 648.49M | -8.67M | -44.17M | -15.27M | -3.19M | 47.25M | 106.23M | 11.99M | -510K | -963K | -7.1M | 5.87M | -6.25M | -20.24M | 532K | 2.91M | -11.02M | -39.43M |
Net Cash Flow | -28.3M | 48.91M | -30.28M | 122.52M | 81.19M | -29.94M | -59.54M | 22.68M | -9.49M | 40.99M | 19.87M | -19.98M | 19.65M | -13.41M | 104.01M | -50.21M | -3.72M | 4.85M | 28.33M | 27.48M | -28.59M |
Free Cash Flow | 92.93M | 64.06M | -5.95M | 7.4M | 89.48M | 13.56M | -13.48M | 31.69M | 20.35M | 5.61M | 12.24M | 11.3M | 23.29M | -7.13M | 84.05M | -39.08M | 7.67M | 6.55M | -14.99M | 42.18M | 14.07M |
Adj. Free Cash Flow | 71.24M | 54.16M | -17.33M | -296K | 77.77M | 5.75M | -28.71M | 25.52M | 12.96M | -140K | 3.57M | 5.59M | 19.07M | -10.58M | 78.43M | -42.58M | 3.75M | 3.49M | -17.42M | 40.76M | 12.51M |
Maintenance CapEx | -7.88M | -4M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -3.1M | -2.01M | n/a | -9.88M | n/a | n/a | n/a | -17.49M | -2.8M | -9.06M | -7.27M |
Growth CapEx | n/a | n/a | -3.06M | -2.55M | -1.42M | -3.07M | -2.53M | -2.3M | -2.84M | -369K | -3.95M | -2.09M | -2.52M | -4.97M | -886K | -3.21M | -1.36M | n/a | n/a | n/a | n/a |
Owner Earnings | 92.93M | 64.06M | -2.89M | 9.96M | 90.9M | 16.63M | -10.95M | 33.98M | 23.19M | 5.98M | 16.2M | 13.39M | 25.8M | -2.16M | 84.94M | -35.87M | 9.02M | 6.55M | -14.99M | 42.18M | 14.07M |
Add to Watchlist
Select watchlists to add or remove ASTH